Evaluation of the joint nurse scientist role across academia and practice.


Journal

Nursing outlook
ISSN: 1528-3968
Titre abrégé: Nurs Outlook
Pays: United States
ID NLM: 0401075

Informations de publication

Date de publication:
Historique:
received: 19 04 2019
revised: 11 09 2019
accepted: 01 10 2019
pubmed: 13 4 2020
medline: 16 7 2020
entrez: 13 4 2020
Statut: ppublish

Résumé

Mapped with the guiding principles of academic-practice partnerships (APPs) outlined by the American Association of Colleges of Nursing and the American Organization for Nursing Leadership, a joint nurse scientist role between a nursing school and acute care facility at a large academic health center was developed and characterized by a PhD-prepared nurse appointed in a research role across organizations. To date, eight faculty are now appointed across the School and four health systems. Describe outcomes, facilitators and vulnerabilities of the joint nurse scientist role. Review of administrative records. Outcomes include the 1) conduct and dissemination of joint research, 2) translation of evidence into practice, 3) development of educational programs for health system nurses, 4) scholarly activities among health system nurses, and 5) improved visibility and valuation of the PhD-prepared nurse. Role facilitators include those previously reported for APPs, the joint nurse scientists' ability to broker opportunities across settings, and the evolving nature of the role. Role vulnerabilities pertain to the negotiation of workload, promotion, and institutional priorities. The joint nurse scientist role fosters shared scholarly successes across academia and service.

Sections du résumé

BACKGROUND
Mapped with the guiding principles of academic-practice partnerships (APPs) outlined by the American Association of Colleges of Nursing and the American Organization for Nursing Leadership, a joint nurse scientist role between a nursing school and acute care facility at a large academic health center was developed and characterized by a PhD-prepared nurse appointed in a research role across organizations. To date, eight faculty are now appointed across the School and four health systems.
PURPOSE
Describe outcomes, facilitators and vulnerabilities of the joint nurse scientist role.
METHODS
Review of administrative records.
DISCUSSION
Outcomes include the 1) conduct and dissemination of joint research, 2) translation of evidence into practice, 3) development of educational programs for health system nurses, 4) scholarly activities among health system nurses, and 5) improved visibility and valuation of the PhD-prepared nurse. Role facilitators include those previously reported for APPs, the joint nurse scientists' ability to broker opportunities across settings, and the evolving nature of the role. Role vulnerabilities pertain to the negotiation of workload, promotion, and institutional priorities.
CONCLUSION
The joint nurse scientist role fosters shared scholarly successes across academia and service.

Identifiants

pubmed: 32278443
pii: S0029-6554(19)30242-8
doi: 10.1016/j.outlook.2019.10.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

261-269

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Eileen J Carter (EJ)

Columbia University School of Nursing, New York, NY; NewYork-Presbyterian Hospital, New York, NY. Electronic address: Em2473@cumc.columbia.edu.

Amanda Hessels (A)

Columbia University School of Nursing, New York, NY; Hackensack University Medical Center, Hackensack, NJ.

Kenrick Cato (K)

Columbia University School of Nursing, New York, NY; NewYork-Presbyterian Hospital, New York, NY.

Carolyn Sun (C)

Columbia University School of Nursing, New York, NY; NewYork-Presbyterian Hospital, New York, NY.

Bevin Cohen (B)

Columbia University School of Nursing, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY.

Reynaldo R Rivera (RR)

NewYork-Presbyterian Hospital, New York, NY.

Elaine Larson (E)

Columbia University School of Nursing, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH